Patient Guide: A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 27 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06941272
Status: 🟢 Enrolling Now
Condition: Malignant Neoplasm
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 27 locations across the country.

Top locations include:
  • • Aurora, Colorado
  • • Iowa City, Iowa
  • • Grand Rapids, Michigan
  • • And 24 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01) - Join Clinical Trial NCTNCT06941272

How to Join This Clinical Trial - NCTNCT06941272

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Malignant Neoplasm. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Malignant Neoplasm. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Malignant Neoplasm
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06941272 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 27 locations. Find a study site near you:

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: RECRUITING

Clinical Research Site

Iowa City, Iowa 52242 - United States

Status: RECRUITING

Clinical Research Site

Grand Rapids, Michigan 49503 - United States

Status: RECRUITING

Clinical Research Site

Kansas City, Missouri 64108 - United States

Status: RECRUITING

Clinical Research Site

New Brunswick, New Jersey 08901 - United States

Status: RECRUITING

Clinical Research Site

Valhalla, New York 10595 - United States

Status: RECRUITING

Clinical Research Site

Fargo, North Dakota 58122 - United States

Status: RECRUITING

Clinical Research Site

Philadelphia, Pennsylvania 19104 - United States

Status: RECRUITING

Clinical Research Site

Sioux Falls, South Dakota 57117 - United States

Status: RECRUITING

Clinical Research Site

Houston, Texas 77030 - United States

Status: RECRUITING

And 17 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Malignant Neoplasm:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships